Trontinemab is a bispecific human IgG1-kappa antibody that targets amyloid beta A4 precursor protein (APP) and transferrin receptor (TFRC).Trontinemab may be used in Alzheimers disease-related studies.
Purity:
99.0%
CAS Number:
[2568868-35-7]
* VAT and and shipping costs not included. Errors and price changes excepted